Literature DB >> 26025499

A log rank type test in observational survival studies with stratified sampling.

Xiaofei Bai1, Anastasios A Tsiatis2.   

Abstract

In randomized clinical trials, the log rank test is often used to test the null hypothesis of the equality of treatment-specific survival distributions. In observational studies, however, the ordinary log rank test is no longer guaranteed to be valid. In such studies we must be cautious about potential confounders; that is, the covariates that affect both the treatment assignment and the survival distribution. In this paper, two cases were considered: the first is when it is believed that all the potential confounders are captured in the primary database, and the second case where a substudy is conducted to capture additional confounding covariates. We generalize the augmented inverse probability weighted complete case estimators for treatment-specific survival distribution proposed in Bai et al. (Biometrics 69:830-839, 2013) and develop the log rank type test in both cases. The consistency and double robustness of the proposed test statistics are shown in simulation studies. These statistics are then applied to the data from the observational study that motivated this research.

Entities:  

Keywords:  Cox proportional hazards model; Log rank test; Observational study; Stratified sampling; Survival analysis

Mesh:

Year:  2015        PMID: 26025499      PMCID: PMC4664585          DOI: 10.1007/s10985-015-9331-2

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  4 in total

1.  Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.

Authors:  Jun Xie; Chaofeng Liu
Journal:  Stat Med       Date:  2005-10-30       Impact factor: 2.373

2.  Contrasting treatment-specific survival using double-robust estimators.

Authors:  Min Zhang; Douglas E Schaubel
Journal:  Stat Med       Date:  2012-07-16       Impact factor: 2.373

3.  Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling.

Authors:  Xiaofei Bai; Anastasios A Tsiatis; Sean M O'Brien
Journal:  Biometrics       Date:  2013-10-11       Impact factor: 2.571

4.  Comparative effectiveness of revascularization strategies.

Authors:  William S Weintraub; Maria V Grau-Sepulveda; Jocelyn M Weiss; Sean M O'Brien; Eric D Peterson; Paul Kolm; Zugui Zhang; Lloyd W Klein; Richard E Shaw; Charles McKay; Laura L Ritzenthaler; Jeffrey J Popma; John C Messenger; David M Shahian; Frederick L Grover; John E Mayer; Cynthia M Shewan; Kirk N Garratt; Issam D Moussa; George D Dangas; Fred H Edwards
Journal:  N Engl J Med       Date:  2012-03-27       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.